Status:
NOT_YET_RECRUITING
Use of Fish Skin Graft (FSG) to Improve Wound Healing and Expedite Discharge at a County Safety-net Hospital
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Surgical Wound
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to estimate the effect of FSG (Kerecis) on hospital length of stay among adult patients with surgical wounds of at least 40cm2 requiring surgical debridement
Eligibility Criteria
Inclusion
- Has wound greater than or equal to 40cm2 requiring surgical debridement
- Agreeable to follow up period of up to 1 year
Exclusion
- Patients with wounds that do not require surgical debridement.
- Patients with a known allergy or other sensitivity to fish material
- Patients who are deemed unlikely to follow up (e.g., patients who live out of state).
- Patients in police custody/incarcerated.
- Patients unable to communicate in either Spanish or English.
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06910189
Start Date
April 15 2025
End Date
November 30 2026
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030